SecBot SecBot
PRESS-RELEASE ·Filed May 18, 2026

QUCY

Quantum Cyber
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago WireGlobeNewswire
Press release · Announcement
Actionable Insight • Neutral

Monitor for any subsequent announcements of contracts, LOIs, or procurement awards following SOF Week. Without disclosed financial commitments, this is a routine industry event participation with no near-term catalyst.

DirectionNeutral
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
QUCY ▼ -60.45% at T+60d
NEUTRAL call -60.45% · α vs SPY -65.31% · entry $3.30 → $1.31
Entry = T+0 close
May 18, 2026
via day close
T+1d
-23.64%
call -23.64% · α -22.99%
$2.52
settled 5mo ago
T+5d
+5.15%
call +5.15% · α +3.53%
$3.47
settled 5mo ago
T+20d
-41.21%
call -41.21% · α -42.79%
$1.94
settled 4mo ago
T+60d
-60.45%
call -60.45% · α -65.31%
$1.31
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Quantum Cyber announced participation as an exhibitor at SOF Week 2026, a premier defense convention. The event provides a platform to showcase its autonomous UAV and counter-UAS technologies to USSOCOM and allied procurement officials, advancing its business development strategy. No financial terms, contracts, or revenue impact were disclosed.

Key Facts

  • Quantum Cyber will exhibit at SOF Week 2026 (May 18-21, Tampa Convention Center), the premier annual convention for global Special Operations Forces.
  • The company will present its autonomous UAV platform with 25km+ range, encrypted comms, and multi-payload reconfigurability.
  • No contracts, orders, or financial commitments were announced in conjunction with the event participation.
  • Market cap is $43M; analyst consensus is 0% bullish (3 Hold, 1 Sell, 2 Strong Sell).

Financial Impact

No financial terms disclosed; event participation is a marketing/business development activity with no immediate revenue impact.

Risk Factors

  • No revenue or contract wins announced — event participation alone does not generate sales.
  • Company has negative analyst sentiment (0% bullish, 3 Hold, 3 Sell/Strong Sell).
  • Forward-looking statements about technology development and commercialization carry execution risk.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3296469
35 reports for QUCY
Performance horizon
67% Hit rate @ T+20 4 of 6 directional calls Went positive at some point 5 of 7 best @ T+60▲ +39.06%Jun 4, 2026
Filters
Rows
Reports for QUCY — sortable, filterable
TypeNow
Oct 26, 2026
today
Press Release
NEUTRAL ★ 2/10
$1.03awaiting T+20—$0.8520 (−17.28%)
Oct 16, 2026
10d ago
8-K
NEUTRAL ★ 2/10
$1.07awaiting T+20—$0.8520 (−20.37%)
Oct 9, 2026
17d ago
8-K
NEUTRAL ★ 4/10
$1.03awaiting T+20—$0.8520 (−17.28%)
Oct 9, 2026
17d ago
424B5
BEARISH ★ 7/10
$1.03awaiting T+20—$0.8520 (+17.28%)
Sep 28, 2026
28d ago
Press Release
NEUTRAL ★ 3/10
$1.36 $0.8515▼ −37.39%▼ −37.36%$0.8520 (−37.35%)
Sep 25, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$1.37 $1.01▼ −26.28%▼ −24.80%$0.8520 (−37.81%)
Sep 25, 2026
4w ago
Press Release
NEUTRAL ★ 3/10
$1.37 $1.01▼ −26.28%▼ −24.80%$0.8520 (−37.81%)
Aug 13, 2026
10w ago
Press Release
NEUTRAL ★ 3/10
$1.42 $1.34▼ −5.63%▼ −3.89%$0.8520 (−40.00%)
Jul 24, 2026
13w ago
8-K
NEUTRAL ★ 4/10
$1.08 $1.30▲ +20.37%▲ +16.74%$0.8520 (−21.11%)
Jul 16, 2026
14w ago
Press Release
NEUTRAL ★ 4/10
$1.19awaiting T+20—$0.8520 (−28.40%)
Showing 10 of 35

US Market Status

Market Closed — Opens in 5h 6m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 18, 2026